Document Basket

Saved pages

Saved documents

Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.


DKSH spurs Asian growth for UK based Clinova

DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Clinova, a UK-based consumer healthcare company, to drive its expansion in four Asian markets.

Media release

DKSH spurs Asian growth for UK based Clinova

DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Clinova, a UK-based consumer healthcare company, to drive its expansion in four Asian markets.

Bangkok, Thailand, March 8, 2017 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, will provide marketing, sales, distribution and logistics as well as regulatory services for Clinova’s range of O.R.S. Hydration Tablets across Asia. Consumers in Hong Kong, Malaysia, Singapore and Thailand will have access to the products in pharmacies and hospitals as well as through e-commerce channels.

 

O.R.S. Hydration Tablets are made from a scientifically balanced formula of electrolytes, glucose and minerals. The soluble tablet prevents dehydration and is particularly suitable for people with an active lifestyle, such as professional and recreational athletes.

 

“With a hot climate and a growing middle class placing high value on personal health, Asia is an increasingly attractive region for Clinova. Building our own Asian growth platform would be costly and time consuming, hence we rely on DKSH to quickly grow into new markets. DKSH’s ability to offer regulatory, commercial and distribution services across multiple channels and markets is invaluable to us,” says Charles Toomey, Chairman APAC, Clinova.

 

“Companies like Clinova that are looking for growth are faced with a decision: will I invest my resources into building a platform or do I buy them? Outsourcing to DKSH provides a fast, low-risk and effective way to grow. With more than 4,200 sales and marketing experts and a broad direct distribution network across health, consumer and e-commerce channels, DKSH’s growth platform is unmatched across Asia,” says Andrew Frye, Head Business Unit Healthcare, DKSH.

 

This agreement will further strengthen DKSH’s market position in the region while contributing gradually to the Group’s overall profitability over time.